Literature DB >> 32298245

Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility - Four U.S. Metropolitan Areas, February 26-April 1, 2020.

Arielle Lasry, Daniel Kidder, Marisa Hast, Jason Poovey, Gregory Sunshine, Kathryn Winglee, Nicole Zviedrite, Faruque Ahmed, Kathleen A Ethier.   

Abstract

Community mitigation activities (also referred to as nonpharmaceutical interventions) are actions that persons and communities can take to slow the spread of infectious diseases. Mitigation strategies include personal protective measures (e.g., handwashing, cough etiquette, and face coverings) that persons can use at home or while in community settings; social distancing (e.g., maintaining physical distance between persons in community settings and staying at home); and environmental surface cleaning at home and in community settings, such as schools or workplaces. Actions such as social distancing are especially critical when medical countermeasures such as vaccines or therapeutics are not available. Although voluntary adoption of social distancing by the public and community organizations is possible, public policy can enhance implementation. The CDC Community Mitigation Framework (1) recommends a phased approach to implementation at the community level, as evidence of community spread of disease increases or begins to decrease and according to severity. This report presents initial data from the metropolitan areas of San Francisco, California; Seattle, Washington; New Orleans, Louisiana; and New York City, New York* to describe the relationship between timing of public policy measures, community mobility (a proxy measure for social distancing), and temporal trends in reported coronavirus disease 2019 (COVID-19) cases. Community mobility in all four locations declined from February 26, 2020 to April 1, 2020, decreasing with each policy issued and as case counts increased. This report suggests that public policy measures are an important tool to support social distancing and provides some very early indications that these measures might help slow the spread of COVID-19.

Entities:  

Mesh:

Year:  2020        PMID: 32298245      PMCID: PMC7755061          DOI: 10.15585/mmwr.mm6915e2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  1 in total

1.  Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017.

Authors:  Noreen Qualls; Alexandra Levitt; Neha Kanade; Narue Wright-Jegede; Stephanie Dopson; Matthew Biggerstaff; Carrie Reed; Amra Uzicanin
Journal:  MMWR Recomm Rep       Date:  2017-04-21
  1 in total
  54 in total

1.  Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste.

Authors:  James T Gordy; Kaushiki Mazumdar; Noton K Dutta
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

2.  COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron).

Authors:  Wan Yang; Jeffrey L Shaman
Journal:  Elife       Date:  2022-08-09       Impact factor: 8.713

3.  Platial mobility: expanding place and mobility in GIS via platio-temporal representations and the mobilities paradigm.

Authors:  Farrukh Chishtie; Rizwan Bulbul; Panka Babukova; Johannes Scholz
Journal:  J Geogr Syst       Date:  2022-07-16

4.  Neighbourhood income and physical distancing during the COVID-19 pandemic in the United States.

Authors:  Jonathan Jay; Jacob Bor; Elaine O Nsoesie; Sarah K Lipson; David K Jones; Sandro Galea; Julia Raifman
Journal:  Nat Hum Behav       Date:  2020-11-03

5.  Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study.

Authors:  Zaid Haddadin; Jennifer E Schuster; Andrew J Spieker; Herdi Rahman; Anna Blozinski; Laura Stewart; Angela P Campbell; Joana Y Lively; Marian G Michaels; John V Williams; Julie A Boom; Leila C Sahni; Mary Staat; Monica McNeal; Rangaraj Selvarangan; Christopher J Harrison; Geoffrey A Weinberg; Peter G Szilagyi; Janet A Englund; Eileen J Klein; Aaron T Curns; Brian Rha; Gayle E Langley; Aron J Hall; Manish M Patel; Natasha B Halasa
Journal:  Pediatrics       Date:  2021-05-13       Impact factor: 7.124

6.  The challenges of data usage for the United States' COVID-19 response.

Authors:  S E Galaitsi; Jeffrey C Cegan; Kaitlin Volk; Matthew Joyner; Benjamin D Trump; Igor Linkov
Journal:  Int J Inf Manage       Date:  2021-04-02

7.  Impact of COVID-19 on Community Participation and Mobility in Young Adults with Autism Spectrum Disorders.

Authors:  Beth Pfeiffer; Eugene Brusilovskiy; Taye Hallock; Mark Salzer; Amber Pompanio Davidson; Laura Slugg; Cecilia Feeley
Journal:  J Autism Dev Disord       Date:  2021-05-14

8.  Observing the silent world under COVID-19 with a comprehensive impact analysis based on human mobility.

Authors:  Shaobin Wang; Yun Tong; Yupeng Fan; Haimeng Liu; Jun Wu; Zheye Wang; Chuanglin Fang
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

9.  COVID-19 Pandemic Causing Depression in Different Sociodemographic Groups in Saudi Arabia.

Authors:  Hana Sonbol; Hadil M Alahdal; Rasis A Alanazi; Khawla Alsamhary; Fuad Ameen
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

10.  Spatial association of mobility and COVID-19 infection rate in the USA: A county-level study using mobile phone location data.

Authors:  Ahmad Ilderim Tokey
Journal:  J Transp Health       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.